eTheRNA: etherna and Dropshot team up to optimise the RNA drug development process in $950m deal
The two companies will combine their LNP and mRNA-based technologies to develop precision medicines for cardiac and renal diseases
Read full article »
eTheRNA is a Belgium-based biotechnology company that researches and develops mRNA immunotherapies for the treatment of cancer.
Read more